baber/WOPTO huggingface dataset:
Patent NZ-502512-A (NZ)
Title: Hard court bowling game and bowl therefor
Inventor: THOMAS HOWARD GRANVILLE
IPC: A63B37/00
Filed: 1998-07-29
Abstract: A bowl for the sport of bowling is disclosed.  In particular this relates firstly to an improved bowl and secondly to an improved playing surface and bowls combination. Broadly according to a first aspect of the invention a biased bowl for use in playing bowls comprises a hard and dense central core (11) and a pliant outer cover (12). The bowl is constructed such that when it is used on a hard surface its rolling and retardation characteristics approximate that of a conventional hard lawn bowl used on a conventional lawn bowling surface. Broadly, according to a second aspect of the invention, a bowling court and bowls combination comprises a bowl as described above and a hard substantially horizontal surface wherein the combination provides an approximation to the conventional lawn bowling combination in terms of bowl rolling and retardation characteristics.
Patent NZ-503591-A (NZ)
Title: Toothbrush with hinge and torsion element for limited rotation
Inventor: HALM HANS
IPC: A61C17/00
Filed: 1998-09-22
Abstract: A toothbrush having a hinge located between its head and its handle, provided by a first and second hinge parts extending respectively from the head end of the toothbrush toward the handle end, and from the handle end toward the head end, in a longitudinally overlapping side by side relationship, the overlapping parts being able to rotate relative to each other through a restricted angle about an axis generally perpendicular to the longitudinal axis, the two parts being linked by a torsion element between them.
Patent NZ-509469-A (NZ)
Title: Trommel screen cleaning with brush and fluid spray nozzle
Inventor: RAYNE STEVEN RONALD
IPC: B03B5/00
Filed: 2001-01-18
Abstract: The trommel screen has a brush and water spray nozzle to assist in screen cleaning.
Patent NZ-509570-A (NZ)
Title: Multi-level security network system and device using a 2-port memory
Inventor: WILLIAMS TIMOTHY C
IPC: H04L29/06
Filed: 1999-07-21
Abstract: A  network  prevents unauthorized users  from  gaining access  to confidential information. The network has various workstations  and servers connected by a common  medium  and through a router to the Internet. The network has two  major components,  a  Network Security Centre (NSC)  and  security network   interface  cards  or  devices.  The  NSC   is   an administrative   workstation  through  which   the   network security officer manages the network as a whole as  well  as the  individual security devices. The security  devices  are interposed, between each of workstation, including the  NSC, and  the common medium and operate at a network layer (layer 3)  of  the  protocol hierarchy. The network allows  trusted users   to   access  outside  information,   including   the Internet,  while stopping outside attackers at  their  point of   entry.  At  the  same  time,  the  network  limits   an unauthorized  insider  to  information  defined   in   their particular  security  profile. The  user  may  select  which virtual  network to access at any given time. The result  is trusted  access to multiple secure Virtual Private  Networks (VPN), all from a single desktop machine
Patent NZ-509682-A (NZ)
Title: Method of treating addictive behaviour by administering a GVG drug also known as the epileptic vigabatrin (sabril)
Inventor: DEWEY STEPHEN L
IPC: A61P25/30
Filed: 1999-08-05
Abstract: A method for changing addiction related behaviour of a subject suffering from addiction to cocaine comprises administrating a composition including gamma vinyl GABA (GVG) in amount an amount to diminish, inhibit or eliminate behaviour associated with cravings, or in an amount to attenuate the rewarding/incentive effects of cocaine in the absence altering rewarding/incentive effects of food. Also described are methods for changing addiction-related behaviour of primate suffering from an addiction to a drug of abuse selected from methamphetamine, morphine and heroin, and methods of ameliorating effects of psychostimulants, narcotic analgesic, alcohol or nicotine addiction and dependency characteristics by administrating GVG.
Patent NZ-513923-A (NZ)
Title: Methods for detecting membrane derived caspase activity and modulators thereof
Inventor: FRITZ LAWRENCE C
IPC: C12Q1/37
Filed: 2000-03-06
Abstract: Caspases (proteases) modulate the apoptotic process thus are significant in maintaining tissue homeostasis and in the pathogenesis of diseases. Disclosed is a method of identifying modulators of the activity of a membrane derived caspase, comprising contacting a membrane fraction with a caspase substrate in the presence and absence of potential inhibitors and comparing the levels of caspase substrate turnover.
Patent NZ-513926-A (NZ)
Title: Methods of treatment of mitochondrial disorders
Inventor: NAVIAUX ROBERT K
IPC: A61K31/00
Filed: 2000-02-23
Abstract: Described is a method of treatment for a non-human mammal that has or is at risk of having mitochondrial disorder. The treatment comprises administering an effective amount of a compound of formula I wherein: R1 is OH, NHCOCH3, or NH2; R2 is H, CO2H, or formula II wherein: X is C1-C22 alkyl, C1-C22 alkenyl or C1-C22 alkynyl, with substituents selected from the group consisting of H, C1-3 alkyl, OH, NH2, and halogen, or wherein X is H; R3, R4 and R5 are independently, optionally substituted c1-c22 alkyl carbonyl, with substituents selected from the group consisting of C1-3 alkyl, OH, NH2 and halogen, or H wherein at least one of the R3, R4 and R5 is not H.
Patent NZ-516502-A (NZ)
Title: Administration of non-oral androgenic steroids to women having an elevated level of sex hormone binding globulin (SHBG)
Inventor: ROSARIO-JANSEN THERESA
IPC: A61P37/00
Filed: 2000-06-09
Abstract: Compositions, methods, and kits for improving health in a woman having elevated sex hormone binding globulin (SHBG) levels, or who is receiving oral estrogen supplementation, by non-orally administering an effective amount of an androgenic steroid are disclosed. Further, the compositions, methods and kits for coadministering an effective amount of an orally administered estrogen and an effective amount of a non-orally administered androgenic steroid for women in need of estrogen supplementation is also disclosed. Fig. 1 shows the change in total testoterone level versus baseline SHBG level during application of transdermal testoterone patch (300 mcg/day nominal delivery) to patients concomitantly receiving transdermal estradiol or oral conjugated equine estrogens.
Patent NZ-518785-A (NZ)
Title: Graft copolymer pigment dispersant
Inventor: MA SHEAU-HWA
IPC: C08F291/00
Filed: 2000-12-15
Abstract: A polymer dispersant for pigments based on an acrylic graft copolymer is disclosed, wherein the graft copolymer has a weight average molecular weight of at least 3000 and has 10 to 90% by weight of a polymeric backbone and 90 to 10% by weight of macromonomer side chains attached to the backbone and wherein the graft copolymer has at least about 1% by weight of a pigment anchoring group selected from the group consisting of an aromatic ester group, aromatic amine group, and quaternary ammonium group, or mixtures thereof, attached to the backbone or the macromonomer. These materials disperse a wide variety of pigments and are useful in solvent borne coatings where they can provide improved efficiency of pigment use, lower paint viscosity, and reduced emission of volatile organic solvent.
Patent NZ-518836-A (NZ)
Title: Closure cap
Inventor: BOSL UDO
IPC: B65D41/04
Filed: 2000-11-01
Abstract: The screw cap for a bottle for CO2-containing drinks has reinforcing ribs (8) on its inside in the area where the top (2) of the cap is connected to its side (4). The ribs terminate before the thread (6) begins.
Patent NZ-520005-A (NZ)
Title: 2-amino-nicotinamide derivatives and their use as VEGF- receptor tyrosine kinase inhibitors for treating disease such as neoplastic, retinopathy or age related macular degeneration
Inventor: MANLEY PAUL WILLIAM
IPC: A61P3/10
Filed: 2001-01-25
Abstract: Use of 2-amino-nicotinamide derivatives of formula (I) or a N-oxide, a possible tautomer thereof or a pharmaceutically acceptable salt of such a compound, alone or in combination with one or more other pharmaceutically active compounds for therapy of a disease which responds to an inhibition of the VEGF-receptor tyrosine kinase activity; and to new 2-amino-nicotinamide derivatives of formula (I) and processes for the preparation thereof is disclosed, wherein: n is from 1 up to and including 6; W is O or S; R1 and R3 represent independently of each other hydrogen, lower alkyl or lower acyl; R2 represents a cycloalkyl group, an aryl group, or a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms and 0, 1 or 2 heteroatoms independently from each other selected from the group consisting of oxygen and sulfur, which groups in each case are unsubstituted or mono- or polysubstituted; R and R' are independently of each other hydrogen or lower alkyl; X represents an aryl group, or a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms and 0, 1 or 2 heteroatoms independently from each other selected from the group consisting of oxygen and sulfur, which groups in each case are unsubstituted or mono- or polysubstituted.
Patent NZ-520075-A (NZ)
Title: Heterocyclic amide derivatives
Inventor: POSS CHRISTOPHER STANLEY
IPC: C07D403/12
Filed: 2001-01-26
Abstract: Compounds of formula (1) that inhibit MIP-1µ binding to the receptor CCR1, and the use thereof to treat conditions treatable by such effect.
Patent NZ-522879-A (NZ)
Title: Cladding systems
Inventor: CASHMORE DAVID MATCHETT ALFRED
IPC: E04C2/26
Filed: 2002-11-28
Abstract: Disclosed is a cladding sheet or slab having an exterior display appearance, and having in cross section a set substrate zone provided by a polymeric binder system and an aggregate, at least substantially embedded by the binder system, and at least one continuous exterior zone on the substrate of at least one set polymeric and/or other material through which some of the aggregate behind the exterior zone can be seen, wherein the substrate zone can be machined from the inside without at least substantial and total disruption of the exterior zone, and wherein the exterior zone, at least when heated above ambient temperatures is flexible and/or pliable.
Patent NZ-523870-A (NZ)
Title: Narrow multi-color ink jet printhead
Inventor: TORGERSON JOSEPH M
IPC: B41J2/21
Filed: 2001-09-07
Abstract: Disclosed is a narrow ink jet printhead (100) having three columnar arrays (61) of ink drop generators configured for multi-pass color printing at a print resolution having a media axis dot spacing that is less than the columnar nozzle spacing of the ink drop generators. The ink jet printhead more particularly includes high resistance heater resistors and efficient FET drive circuits that are configured to compensate for variation in parasitic resistance presented by power traces (86a, 86b, 86c, 86d, 181).
Patent NZ-526539-A (NZ)
Title: DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
Inventor: THOMPSON JOHN E
IPC: C12N15/29
Filed: 2001-11-29
Abstract: A method for increasing resistance to physiological disease in a plant comprises integrating into the genome of the plant a vector comprising an antisense nucleotide and a regulatory sequences operatively linked to the antisense nucleotide sequences such that the antisense nucleotide sequences are expressed, and then growing the plant, whereby said antisense nucleotide sequences are transcribed and bind to the RNA sequence, whereby expression of said senescence-induced deoxyhypusine synthase gene, senescence-induced eIF-5A gene or both is inhibited. The antisense nucleotide sequences are selected from sequences encoding the 3'end of endogenous senescence-induced deoxyhypusine synthase, and encoding the endogenous senescence-induced eIF-5A gene.
Patent NZ-527918-A (NZ)
Title: Adenosine receptor antagonists and methods of making and using the same
Inventor: DOWLING JAMES E
IPC: A61P25/28
Filed: 2003-09-01
Abstract: A method of making 8-substituted xanthines of the formula (I) wherein: R1 and R2 are independently hydrogen, or optionally substituted alkyl, alkenyl, alkynyl or aryl; R3 is an optionally substituted bicyclic, tricyclic or pentacyclic group of formula (II); X1 and X2 are independently O or S; Z is a single bond, -O-, -(CH2)1-3-, -O(CH2)1-2-, -CH2OCH2-, -(CH2)1-2O-, -CH=CHCH2-, -CH=CH- or -CH2CH=CH- and R6 is hydrogen, alkyl, acyl, alkylsulphonyl, optionally substituted aralkyl or alkyl or heterocyclyl. (62) Divided out of 519427
Patent NZ-528319-A (NZ)
Title: Tissue array instrument comprising two punch units, each unit including a stylet
Inventor: LEIGHTON STEPHEN B
IPC: G01N35/00
Filed: 2002-03-19
Abstract: Arrays of biological tissue can be created by removing cores from regions of interest in a series of donor blocks of embedded tissues. The cores removed are placed in a regular array in a recipient block. This is typically done with two different punches, one for obtaining the cores of interest and the other for creating the receiving holes in the recipient block. The system includes two separate z axes, one for each punch. Each punch has its own stylet and the axis of each punch is parallel to the axis of its drive. Alternatively, a single z axis is provided, with a mechanism for automatically changing two or more punches in and out of a holder on the z axis.
Patent NZ-530089-A (NZ)
Title: A process for storing enriched nematodes for use in aquaculture
Inventor: SEMACH SHALOM
IPC: A23K1/18
Filed: 2002-06-04
Abstract: A process for preserving and storing nematodes having an increased feeding value for later use as needed in the feeding of aquaculture organisms. In this process, nematodes are enriched with an additive such as essential fatty acids, vaccines, hormones, immunostimulants, attractants, nutrients and pigments. Liposomes can serve as a medium for feeding the additives to the nematodes. The enriched nematodes are then desiccated by inducing a quiescent anhydrobiosis (dehydration) and stored for off-the-shell use as needed. When required for feeding, the desiccated enriched nematodes are re-hydrated and fed to the aquaculture organisms.
Patent NZ-530994-A (NZ)
Title: Post anchor
IPC: E04H12/22
Filed: 2004-02-05
Abstract: A post anchor comprising a holder to receive and hold at least one post. A ground engaging member for driving into the ground is attached to the holder and is made up of a central web and first and second flanges. The first flange extends away from a first side of the web and said second flange extends from the second side. The web and both flanges are integrally formed.
Patent NZ-531854-A (NZ)
Title: Aminobenzamide derivatives as glycogen synthase kinase 3beta inhibitors
Inventor: FREYEN EDDY JEAN EDGARD
IPC: C07D239/42
Filed: 2002-10-29
Abstract: Disclosed are compounds of formula (I), wherein: R1 is H, aryl, formyl, alkylcarbonyl, alkyl, substituted alkyloxycarbonyl or substituted alkyloxyalkylcarbonyl, R2 is H, alkyl, alkenyl, alkynyl, R20, each optionally substituted, R4a and R4b are independently H or alkyl, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases mediated through GSK3.
Patent NZ-532443-A (NZ)
Title: Stents having coagulation factor Xa useful for treating thromboses and restenoses
Inventor: PERZBORN ELISABETH
IPC: A61F2/82
Filed: 2002-10-11
Abstract: Stents containing oxazolidinones of formula (I) which act as anticoagulants and are selective inhibitors of coagulation factor Xa; and methods for making these stents are disclosed, wherein the substituents R1 to R8 are as defined in the specification. These stents are suitable for use in treating thromboses and restenoses.
Patent NZ-536887-A (NZ)
Title: PRO 1800 polypeptides and diagonistic methods and treatment of neoplastic diseases
IPC: C12N9/02
Filed: 1999-12-01
Abstract: A diagnostic method comprises detecting expression of PRO1800 (SEQ ID NO:2) in a test sample wherein higher expression of a polypeptide of SEQ ID NO:2 in the test sample as compared to a control sample correlates with the presence of a neoplastic disease. Also described is the use of an antibody, or sense or antisense polynucleotide capable of blocking the expression of the polypeptide of SEQ ID NO:2 in the manufacture of a medicament for treating neoplastic diseases.
Patent NZ-537875-A (NZ)
Title: A multilayered catalyst configuration and methods for syngas production
Inventor: JIANG WEIBIN
IPC: B01J21/06
Filed: 2005-01-25
Abstract: A catalyst composition comprising a first layer of a catalytically active metal selected from the group consisting of nickel, cobalt, iron, platinum, palladium, iridium, rhenium, ruthenium, rhodium, osmium and combinations thereof dispersed on an inert monolithic carrier support having a honeycomb shape and is made from a material selected from the group consisting of alumina, mullite, zirconia, partially stabilised zirconia, ceria, silica, silicon carbide, silicon nitride, silicon nitride ceramic, aluminium nitride, boron nitride, aluminosilicate magnesium aluminosilicates, a combination of magnesium aluminosilicates and aluminosilicate, and mixtures of these and a second layer of a reduced metal catalyst consisting essentially of a transition metal selected from the group consisting of nickel, cobalt, iron, platinum, palladium, iridium, rhenium, ruthenium, rhodium, osmium, and combinations thereof supported on or in a stable inorganic metal oxide selected from the group consisting of oxides comprising one or more cations selected from groups IA, IA, lIlA and IVA of the Periodic Table of the Elements, the transition metals and mixtures of these washcoated on a support. The catalyst is for the partial oxidation of hydrocarbons to produce hydrogen and carbon monoxide, by contacting a mixture of a hydrocarbon containing feed gas and an oxygen containing feed gas with the catalyst.
Patent NZ-540480-A (NZ)
Title: Keg with an inner bag
Inventor: ANDERSON IAN
IPC: B67D1/00
Filed: 2003-11-25
Abstract: An interlocking collar secures a bag neck in a keg aperture of an alcohol beverage keg container. The interlocking collar is mounted in press fit surrounding relation with a peripheral wall portion of the bag neck. The collar has an outer peripheral wall portion sized larger than that of a keg aperture. The collar has a recessed groove in the collar outer peripheral wall portion for receiving in press fitting and sealing relation a keg flange that defines the keg aperture. The collar outer peripheral wall portion has a resilient edge portion adjacent the recessed groove that deflects to permit the interlocking collar to pass through the keg aperture and receive the keg flange in the recessed groove. The interlocking collar has a plurality of locking passageways placed around the interlocking collar and axially extending through the interlocking collar between the neck and recessed grove. A latch member has a plurality of locking fingers that extend axially though the locking passageways to prevent deflection of the resilient edge portion of the interlocking collar after the collar is placed in the keg aperture
Patent NZ-545493-A (NZ)
Title: Plant cell cycle genes and methods of use
Inventor: YAO JIALONG
IPC: C12N15/82
Filed: 2004-07-28
Abstract: Disclosed is a method for modulating plant growth and biomass, comprising the step of stably incorporating into the genome of the plant, a recombinant genetic construct that comprises, in the 5' to 3' direction: (a) a gene promoter sequence; (b) a polynucleotide having the sequence of SEQ ID NO: 13; and (c) a gene termination sequence.
Patent NZ-545595-A (NZ)
Title: Curved positioning and insertion instrument for inserting a guide wire into the femur
Inventor: KAUP THOMAS
IPC: A61B17/17
Filed: 2004-03-08
Abstract: A curved positioning and insertion instrument for inserting a guide wire (50) into the femur has a curved guide tube (2) with a distal end to be placed on the trochanter (not shown) and/or the medial muscle (45) and a proximal end for inserting a guide wire (50). The instrument also has a holding arm (4) that links the guide tube (2) to a handle (5). A positioning hook fitted with at least one correction bore (not shown) for receiving the guide wire (50) or another guide wire is arranged at the distal end of the guide tube (2). This structure makes it possible to easily insert further or additional guide wires (50) relative to a reference guide wire (50).
Patent NZ-548684-A (NZ)
Title: Novel inhibitors of chymase
Inventor: GRECO MICHAEL N
IPC: A61K31/165
Filed: 2005-01-18
Abstract: Disclosed is a compound of formula (I), or pharmaceutically acceptable salts thereof, where n is 0 or 1, W is O or S, Y is SO3H or P(-O)OR5R6, Z is a monocyclic or polycyclic ring system, and wherein the rest of the subtituents are disclosed in the specification. Also disclosed is the suitability of the above compound for treating chymase mediated disorders such as allergic rhinitis, viral rhinitis, asthma, chronic obstructive pulmonary diseases, bronchitis, pulmonary emphysema, psoriasis, arthritis, reperfusion injury, ischemia, hypertension, hypercardia myocardial infarction, heart failure damage associated with myocardial infarction, cardiac hypertrophy, arteriosclerosis, saroidosis, vascular stenosis or restenosis (e.g. associated with vascular injury, angioplasty, vascular stents or vascular grafts), pulmonary fibrosis, kidney fibrosis (e.g. associated with glomerulonephritis), liver fibrosis, post surgical adhesion formation, systemic sclerosis, keloid scars, rheumatoid arthritis, bullous pemphigiod and atherosclerosis.
Patent NZ-554399-A (NZ)
Title: Potentiators of glutamate receptors
Inventor: AICHER THOMAS DANIEL
IPC: A61K31/4427
Filed: 2005-11-15
Abstract: Provided are 3-{[4-(4-Acetyl-3-hydroxy-2-propyl-phenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid and related compounds which are useful in the treatment of migraine. The compounds are potentiators of mGlu2 receptor and antagonists of the CysLT1 receptor and provide a means to treat disorders associated with glutamate or leukotrienes.
Patent NZ-562855-A (NZ)
Title: A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
Inventor: BROWITT RODNEY JAMES
IPC: A61K51/12
Filed: 2006-04-28
Abstract: A method of forming an injectable radioactive composition is disclosed, wherein the method comprises the steps of: (a) depositing a solid form of radioactive isotope (such as technetium) and carrier (such as sodium chloride) onto a carbon crucible; (b) preheating the solid form of radioactive isotope and carrier to remove the carrier; (c) plasma ablating the radioactive particle and portions of the carbon crucible; the method may further comprise the steps of: (d) allowing the carbon and technetium metal to co-condense from the gas phase to produce a nanoparticle composite aerosol in an inert gas; (e) dispersing the nanoparticle composite in water containing a low concentration of surfactant using an electrostatic precipitator; and (f) size fractionating the nanoparticle dispersion by filtration with hydrophilic membranes of known pore size.